Streetbeat News

Regulatory

ABBV

ATAI

COMP

JNJ

MNMD

PFE

The global psychedelic drugs market is expected to grow by $1.37 billion from 2024 to 2028, driven by mental health disorders and AI integration. Key players include AbbVie, ATAI Life Sciences, COMPASS Pathways, Johnson & Johnson, Pfizer, and Mind Medicine. Despite growth potential, regulatory challenges and ethical concerns remain.

Portfolio Pulse from Juan Spínelli

September 05, 2024 | 4:53 pm

SLM

SOFI

SPY

A U.S. judge has temporarily blocked President Biden's new student debt forgiveness plan following a request from Republican-led states. This legal development could impact companies involved in student loans and financial services.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 4:51 pm

HIMS

LLY

NVO

Hims & Hers Health, Inc. (HIMS) is offering affordable compounded weight-loss medications as alternatives to Eli Lilly's (LLY) Zepbound and Novo Nordisk's (NVO) Wegovy. This strategy has led to a significant stock price increase for HIMS. However, regulatory challenges may arise as pharmaceutical companies increase production to meet demand, potentially affecting HIMS' business model.

Portfolio Pulse from Vandana Singh

September 05, 2024 | 4:47 pm

MODD

Modular Medical, Inc. (NASDAQ:MODD) shares rose after receiving FDA clearance to market its MODD1 pump in the U.S. The pump, aimed at making diabetes technology more accessible, is expected to be available in early 2025. Despite initial gains, the stock has since retracted some of its increase.

Portfolio Pulse from Erica Kollmann

September 05, 2024 | 4:11 pm

MODD

Modular Medical shares are rising following the announcement of a conference call to discuss FDA clearance of its MODD1 pump and future plans.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 4:02 pm

IMRN

Immuron is planning a Phase 2 trial for its drug IMM-529 following a review by the FDA. This development is significant for the company's progress in drug development.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 3:59 pm

MODD

Modular Medical, Inc. (NASDAQ:MODD) announced FDA clearance for its MODD1 insulin pump and will host a conference call to discuss next steps and milestones.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 3:56 pm

SPY

Donald Trump plans to announce economic proposals, including a government efficiency commission recommended by Elon Musk, a corporate tax rate cut to 15% for U.S. manufacturers, and rescinding unspent funds from the Biden administration.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 3:48 pm